TickerGuard
Buy Day today: Neutral (63) Broad market participation · major macro event coming up
TRAX

First Tracks Biotherapeutics, Inc.

Healthcare · Biotechnology · —

49.00$ +5.8% vs. previous close Closing price · As of: Nov 4, 2026

Investor relations

Report Dates

Investor relations overview for First Tracks Biotherapeutics, Inc. (TRAX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/11/2026.

Next report 11/11/2026
Last report 08/12/2026
Earnings surprise by quarter (%)
Q1 26 · -164.4 % 26 Q2 26 · -28.4 % 26

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 11/03/2026 First Tracks Biotherapeutics, Inc. (TRAX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/20/2026 First Tracks Biotherapeutics, Inc. (TRAX): Entry into a Material Definitive Agreement; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/15/2026 First Tracks Biotherapeutics, Inc. (TRAX): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/13/2026 First Tracks Biotherapeutics, Inc. (TRAX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/12/2026 First Tracks Biotherapeutics, Inc. (TRAX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?